Lineage relationships of human interleukin-22-producing CD56+ RORgt1 innate lymphoid cells and conventional natural killer cells

Blood

Volumn 121, Issue 12, 2013, Pages 2234-2243

  Ahn, Yong Oon ^a   Blazar, Bruce R ^a   Miller, Jeffrey S ^b   Verneris, Michael R ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA4 INTEGRIN; AROMATIC HYDROCARBON RECEPTOR; B CELL ACTIVATING FACTOR; CD16 ANTIGEN; CD161 ANTIGEN; CD56 ANTIGEN; CD7 ANTIGEN; CD94 ANTIGEN; FLT3 LIGAND; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 15; INTERLEUKIN 22; INTERLEUKIN 7; INTERLEUKIN 8; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MESSENGER RNA; MUCOSAL ADDRESSIN CELL ADHESION MOLECULE 1; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 1; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 2; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 3; NATURAL KILLER CELL RECEPTOR NKG2D; OX40 LIGAND; PERFORIN; RETINOID RELATED ORPHAN RECEPTOR GAMMA; STEM CELL FACTOR RECEPTOR; TRANSCRIPTION FACTOR EOMES; TRANSCRIPTION FACTOR T BET; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1; CYTOKINE RECEPTOR; INTERLEUKIN DERIVATIVE; INTERLEUKIN-22;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL LINEAGE; CELL MIGRATION; EMBRYO; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPHENOTYPING; IN VITRO STUDY; INTERFERON PRODUCTION; LYMPHOID CELL; MOUSE; NATURAL KILLER CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; CELL CULTURE; CELL STRAIN K 562; GENETICS; IMMUNOLOGY; LYMPHOCYTE; LYMPHOCYTE ACTIVATION; METABOLISM; PHYSIOLOGY; TRANSGENIC MOUSE;

ANIMALS; ANTIGENS, CD56; CELL DIFFERENTIATION; CELL LINEAGE; CELLS, CULTURED; HUMANS; INTERLEUKINS; K562 CELLS; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; MICE; MICE, TRANSGENIC; NUCLEAR RECEPTOR SUBFAMILY 1, GROUP F, MEMBER 3; RECEPTORS, CYTOKINE;

MLCS; MLOWN;

EID: 84877930373     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2012-07-440099     Document Type: Article

References (53)

1. Spits H, Di Santo JP. The expanding family of innate lymphoid cells: Regulators and effectors of immunity and tissue remodeling. Nat Immunol. 2011;12(1):21-27.
2. Spits H, Cupedo T. Innate lymphoid cells: Emerging insights in development, lineage relationships, and function. Annu Rev Immunol. 2012;30:647-675.
3. Yokota Y, Mansouri A, Mori S, et al. Development of peripheral lymphoid organs and natural killer cells depends on the helix-loop-helix inhibitor Id2. Nature. 1999;397(6721):702-706.
4. Neill DR, Wong SH, Bellosi A, et al. Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity. Nature. 2010; 464(7293):1367-1370.
5. Yasuda K, Muto T, Kawagoe T, et al. Contribution of IL-33-activated type II innate lymphoid cells to pulmonary eosinophilia in intestinal nematodeinfected mice. Proc Natl Acad Sci USA. 2012; 109(9):3451-3456.
6. Cella M, Fuchs A, Vermi W, et al. A human natural killer cell subset provides an innate source of IL- 22 for mucosal immunity. Nature. 2009; 457(7230):722-725.
7. Tang Q, Ahn YO, Southern P, et al. Development of IL-22-producing NK lineage cells from umbilical cord blood hematopoietic stem cells in the absence of secondary lymphoid tissue. Blood. 2011;117(15):4052-4055.
8. Eberl G, Marmon S, Sunshine MJ, et al. An essential function for the nuclear receptor RORgamma(t) in the generation of fetal lymphoid tissue inducer cells. Nat Immunol. 2004;5(1): 64-73.
9. Cupedo T, Crellin NK, Papazian N, et al. Human fetal lymphoid tissue-inducer cells are interleukin 17-producing precursors to RORC1 CD1271 natural killer-like cells. Nat Immunol. 2009;10(1): 66-74.
10. Hughes T, Becknell B, McClory S, et al. Stage 3 immature human natural killer cells found in secondary lymphoid tissue constitutively and selectively express the TH 17 cytokine interleukin- 22. Blood. 2009;113(17):4008-4010.
11. Cella M, Otero K, Colonna M. Expansion of human NK-22 cells with IL-7, IL-2, and IL-1beta reveals intrinsic functional plasticity. Proc Natl Acad Sci USA. 2010;107(24):10961-10966.
12. Sanos SL, Bui VL, Mortha A, et al. RORgammat and commensal microflora are required for the differentiation of mucosal interleukin 22-producing NKp461 cells. Nat Immunol. 2009;10(1):83-91.
13. Vonarbourg C, Mortha A, Bui VL, et al. Regulated expression of nuclear receptor RORgt confers distinct functional fates to NK cell receptorexpressing RORgt(1) innate lymphocytes. Immunity. 2010;33(5):736-751.
14. Freud AG, Caligiuri MA. Human natural killer cell development. Immunol Rev. 2006;214:56-72.
15. Colonna M. Interleukin-22-producing natural killer cells and lymphoid tissue inducer-like cells in mucosal immunity. Immunity. 2009;31(1):15-23.
16. Freud AG, Yokohama A, Becknell B, et al. Evidence for discrete stages of human natural killer cell differentiation in vivo. J Exp Med. 2006; 203(4):1033-1043.
17. Satoh-Takayama N, Lesjean-Pottier S, Vieira P, et al. IL-7 and IL-15 independently program the differentiation of intestinal CD3-NKp461 cell subsets from Id2-dependent precursors. J Exp Med. 2010;207(2):273-280.
18. Crellin NK, Trifari S, Kaplan CD, et al. Human NKp441IL-221 cells and LTi-like cells constitute a stable RORC1 lineage distinct from conventional natural killer cells. J Exp Med. 2010; 207(2):281-290.
19. Grzywacz B, Kataria N, Kataria N, et al. Natural killer-cell differentiation by myeloid progenitors. Blood. 2011;117(13):3548-3558.
20. Grzywacz B, Kataria N, Sikora M, et al. Coordinated acquisition of inhibitory and activating receptors and functional properties by developing human natural killer cells. Blood. 2006;108(12):3824-3833.
21. Montaldo E, Vitale C, Cottalasso F, et al. Human NK cells at early stages of differentiation produce CXCL8 and express CD161 molecule that functions as an activating receptor. Blood. 2012; 119(17):3987-3996.
22. McCullar V, Oostendorp R, Panoskaltsis-Mortari A, et al. Mouse fetal and embryonic liver cells differentiate human umbilical cord blood progenitors into CD56-negative natural killer cell precursors in the absence of interleukin-15. Exp Hematol. 2008;36(5):598-608.
23. Di Santo JP. An IL-1beta-dependent switch in innate mucosal immunity? Immunity. 2010;32(6): 734-736
24. Hughes T, Becknell B, Freud AG, et al. Interleukin-1beta selectively expands and sustains interleukin-221 immature human natural killer cells in secondary lymphoid tissue. Immunity. 2010;32(6):803-814.
25. Walzer T, Bléry M, Chaix J, et al. Identification, activation, and selective in vivo ablation of mouse NK cells via NKp46. Proc Natl Acad Sci USA. 2007;104(9):3384-3389.
26. Lee JS, Cella M, McDonald KG, et al. AHR drives the development of gut ILC22 cells and postnatal lymphoid tissues via pathways dependent on and independent of Notch. Nat Immunol. 2012;13(2): 144-151.
27. Gordon SM, Chaix J, Rupp LJ, et al. The transcription factors T-bet and Eomes control key checkpoints of natural killer cell maturation. Immunity. 2012;36(1):55-67.
28. Crellin NK, Trifari S, Kaplan CD, et al. Regulation of cytokine secretion in human CD127(1) LTi-like innate lymphoid cells by Toll-like receptor 2. Immunity. 2010;33(5):752-764.
29. Sereti I, Dunham RM, Spritzler J, et al; ACTG 5214 Study Team. IL-7 administration drives T cell-cycle entry and expansion in HIV-1 infection. Blood. 2009;113(25):6304-6314.
30. Satoh-Takayama N, Vosshenrich CA, Lesjean- Pottier S, et al. Microbial flora drives interleukin 22 production in intestinal NKp461 cells that provide innate mucosal immune defense. Immunity. 2008; 29(6):958-970.
31. Vacca P, Vitale C, Montaldo E, et al. CD341 hematopoietic precursors are present in human decidua and differentiate into natural killer cells upon interaction with stromal cells. Proc Natl Acad Sci USA. 2011;108(6):2402-2407.
32. Ivanov II, McKenzie BS, Zhou L, et al. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-171 T helper cells. Cell. 2006;126(6):1121-1133.
33. Scandella E, Bolinger B, Lattmann E, et al. Restoration of lymphoid organ integrity through the interaction of lymphoid tissue-inducer cells with stroma of the T cell zone. Nat Immunol. 2008; 9(6):667-675.
34. Avery S, Shi W, Lubin M, et al. Influence of infused cell dose and HLA match on engraftment after double-unit cord blood allografts. Blood. 2011;117(12):3277-3285, quiz 3478.
35. Avery S, Barker JN. Cord blood transplants: One, two or more units? Curr Opin Hematol. 2010; 17(6):531-537
36. Sawa S, Cherrier M, Lochner M, et al. Lineage relationship analysis of RORgammat1 innate lymphoid cells. Science. 2010;330(6004): 665-669.
37. Nishi T, Okazaki K, Kawasaki K, et al. Involvement of myeloid dendritic cells in the development of gastric secondary lymphoid follicles in Helicobacter pylori-infected neonatally thymectomized BALB/c mice. Infect Immun. 2003; 71(4):2153-2162.
38. Bouskra D, Brézillon C, Bérard M, et al. Lymphoid tissue genesis induced by commensals through NOD1 regulates intestinal homeostasis. Nature. 2008;456(7221):507-510.
39. Marchesi F, Martin AP, Thirunarayanan N, et al. CXCL13 expression in the gut promotes accumulation of IL-22-producing lymphoid tissueinducer cells, and formation of isolated lymphoid follicles. Mucosal Immunol. 2009;2(6):486-494.
40. Miller JS, McCullar V. Human natural killer cells with polyclonal lectin and immunoglobulinlike receptors develop from single hematopoietic stem cells with preferential expression of NKG2A and KIR2DL2/L3/S2. Blood. 2001;98(3):705-713.
41. Yoshida H, Naito A, Inoue J, et al. Different cytokines induce surface lymphotoxin-alphabeta on IL-7 receptor-alpha cells that differentially engender lymph nodes and Peyer's patches. Immunity. 2002;17(6):823-833.
42. Tumanov AV, Koroleva EP, Guo X, et al. Lymphotoxin controls the IL-22 protection pathway in gut innate lymphoid cells during mucosal pathogen challenge. Cell Host Microbe. 2011;10(1):44-53.
43. Kim MY, Anderson G, White A, et al. OX40 ligand and CD30 ligand are expressed on adult but not neonatal CD41CD3- inducer cells: Evidence that IL-7 signals regulate CD30 ligand but not OX40 ligand expression. J Immunol. 2005;174(11): 6686-6691.
44. Kennedy MK, Glaccum M, Brown SN, et al. Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice. J Exp Med. 2000;191(5):771-780.
45. Lodolce JP, Boone DL, Chai S, et al. IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation. Immunity. 1998;9(5):669-676.
46. Chappaz S, Gärtner C, Rodewald HR, et al. Kit ligand and Il7 differentially regulate Peyer's patch and lymph node development. J Immunol. 2010; 185(6):3514-3519.
47. Moore TA, von Freeden-Jeffry U, Murray R, et al. Inhibition of gamma delta T cell development and early thymocyte maturation in IL-7 -/- mice. J Immunol. 1996;157(6):2366-2373.
48. He YW, Malek TR. Interleukin-7 receptor alpha is essential for the development of gamma delta 1 T cells, but not natural killer cells. J Exp Med. 1996;184(1):289-293.
49. Barao I, Hudig D, Ascensao JL. IL-15-mediated induction of LFA-1 is a late step required for cytotoxic differentiation of human NK cells from CD341Lin- bone marrow cells. J Immunol. 2003; 171(2):683-690.
50. Barber DF, Faure M, Long EO. LFA-1 contributes an early signal for NK cell cytotoxicity. J Immunol. 2004;173(6):3653-3659.
51. Milush JM, Long BR, Snyder-Cappione JE, et al. Functionally distinct subsets of human NK cells and monocyte/DC-like cells identified by coexpression of CD56, CD7, and CD4. Blood. 2009;114(23):4823-4831.
52. Geremia A, Arancibia-Cárcamo CV, Fleming MP, et al. IL-23-responsive innate lymphoid cells are increased in inflammatory bowel disease. J Exp Med. 2011;208(6):1127-1133.
53. Takayama T, Kamada N, Chinen H, et al. Imbalance of NKp44(1)NKp46(-) and NKp44(-) NKp46(1) natural killer cells in the intestinal mucosa of patients with Crohn's disease. Gastroenterology. 2010;139(3):882-892, 892.e1-3.